Ensartinib for EML4-ALK-positive lung adenocarcinoma with comorbid mutations in TP53, EGFR, and ERBB2: a case report - Huang, Xiaoqing; Zhou, Lingxian; Xia, Jianyong; Jian, Haifeng; Liu, Jinji; Huang, Yunying; Chen, Qingsheng (Frontiers in Oncology, 2025)